2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $797M | $924M | $988M | $974M | $835M |
Cost of Revenue | $440M | $539M | $593M | $657M | $639M |
Gross Profit | $357M | $385M | $395M | $317M | $196M |
Gross Profit % | 45% | 42% | 40% | 33% | 23% |
R&D Expenses | $98M | $113M | $107M | $109M | $101M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $86M | $62M | $11M | -$28M | -$138M |
Dep. & Amort. | $49M | $67M | $93M | $97M | $88M |
Def. Tax | -$3M | -$1.1M | -$2.4M | -$60M | -$32M |
Stock Comp. | $27M | $28M | $38M | $43M | $42M |
Chg. in WC | -$43M | -$63M | -$158M | -$79M | $77M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $227M | $114M | $66M | $72M | $181M |
ST Investments | $2M | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $227M | $114M | $66M | $72M | $181M |
Receivables | $211M | $292M | $448M | $507M | $415M |
Inventory | $178M | $222M | $270M | $337M | $335M |
MRCY reported strong Q2 FY25 results, with revenue of $223M, up 13% year-over-year, and adjusted EBITDA of $22M, reflecting a margin of 9.9%.
The company achieved record free cash flow of $82M in the quarter, driven by improved cash management and reduced net working capital by $115M year-over-year.
MRCY's backlog reached a record $1.4B, with a trailing 12-month book-to-bill ratio of 1.12, supported by competitive wins and production-focused bookings.
The company expects FY25 revenue growth approaching mid-single digits and low double-digit adjusted EBITDA margins, with Q4 margins anticipated to be the highest of the fiscal year.
MRCY continues to focus on transitioning from development to production programs, improving backlog margins, and achieving long-term adjusted EBITDA margins in the low to mid-20% range.